Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sales of Zai Lab’s PARP Inhibitor Reaching RMB46.90 Million in Macau, S.A.R., China and Hong Kong, S.A.R., China of China in 2019

PharmaSources/CaicaiMarch 31, 2020

Tag: PARP inhibitor , Zai Lab , Niraparib , 2019

PharmaSources Customer Service